Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Daniel Picard
Affiliation
Groupe Hospitalier Universitaire Pitie-Salpetriere
ORCID
Career Start Year
1981
Papers
108
H Index
26
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36301489
CD155 is a putative therapeutic target in medulloblastoma.
Clin Transl Oncol
2023
37656187
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.
Acta Neuropathol
2023
37582744
Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors.
Mol Cancer
2023
35842351
Contribution of the Synkinesis Assessment Questionnaire and the Sunnybrook Facial Grading System to the evaluation of synkinesis after peripheral facial palsy: A STROBE observational study.
Eur Ann Otorhinolaryngol Head Neck Dis
2023
37215954
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease.
Neurooncol Adv
2023
37183219
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
2023
37469802
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic Leukemia.
Hemasphere
2023
36741356
Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens.
Hemasphere
2023
36639156
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
J Immunother Cancer
2023
36824296
Resolving inherited and <i>de novo</i> germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies.
Front Pediatr
2023
36627300
Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Nat Commun
2023
36481611
Cochlear implantation and facial nerve anastomosis to rehabilitate a burnt middle ear.
Am J Otolaryngol
2023
34810198
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment.
Cancer Res
2022
35650266
Persister state-directed transitioning and vulnerability in melanoma.
Nat Commun
2022
35379801
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.
Cell Death Discov
2022
35831316
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
Nat Commun
2022
36473869
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
Nat Commun
2022
36127323
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.
Cell Death Dis
2022
35951329
Nasal and Pharyngeal Coil Extrusion After Embolization of an Internal Carotid Artery Pseudoaneurysm.
JAMA Otolaryngol Head Neck Surg
2022
35281473
Temporal Characterization of Microglia-Associated Pro- and Anti-Inflammatory Genes in a Neonatal Inflammation-Sensitized Hypoxic-Ischemic Brain Injury Model.
Oxid Med Cell Longev
2022
35307743
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis.
Neuro Oncol
2022
35334498
Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology.
Biotechnol J
2022
35228525
Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation.
Cell Death Discov
2022
32594233
Oro-facial motor assessment: validation of the MBLF protocol in facial palsy.
Eur Arch Otorhinolaryngol
2021
33629064
Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.
Neurooncol Adv
2021
33600825
Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition.
J Invest Dermatol
2021
33866410
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
Acta Neuropathol
2021
35050997
Pain in Patients with Post Paralytic Hemifacial Spasm: Before, during and after Botulinum Toxin Injections.
Toxins (Basel)
2021
34584066
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.
Cell Death Dis
2021
34628166
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.
Biomed Pharmacother
2021
34079902
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression.
ACS Cent Sci
2021
34359754
Identification and Functional Characterization of Novel MYC-Regulated Long Noncoding RNAs in Group 3 Medulloblastoma.
Cancers (Basel)
2021
34337410
Expression of cell type incongruent alpha-cardiac actin 1 subunit in medulloblastoma reveals a novel mechanism for cancer cell survival and control of migration.
Neurooncol Adv
2021
34336858
The Second Oncogenic Hit Determines the Cell Fate of <i>ETV6-RUNX1</i> Positive Leukemia.
Front Cell Dev Biol
2021
33036789
[Sequelae in bell's palsy: Prognostic factors for recovery].
Ann Chir Plast Esthet
2021
31225627
ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.
Neurosurgery
2020
33123073
Involvement of CXCL1/CXCR2 During Microglia Activation Following Inflammation-Sensitized Hypoxic-Ischemic Brain Injury in Neonatal Rats.
Front Neurol
2020
32642697
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity.
Neurooncol Adv
2020
32585856
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA.
Int J Mol Sci
2020
30530705
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
Clin Cancer Res
2019
31683879
A Sexually Dimorphic Role for STAT3 in Sonic Hedgehog Medulloblastoma.
Cancers (Basel)
2019
30093397
The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells.
Haematologica
2019
30867410
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Cell Death Dis
2019
31081944
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.
Int J Cancer
2019
30674530
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.
Cancer Res
2019
29490009
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Brain
2018
30205043
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Cancer Cell
2018
30248342
Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability.
Am J Pathol
2018
28516419
Abstracts of the 52nd Workshop for Pediatric Research : Frankfurt, Germany. 27-28 October 2016.
Mol Cell Pediatr
2017
28379574
The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
Neuro Oncol
2017
1 - 50 of 108
Column Actions
Search
Recommended Authors
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year
2007
Number of shared co-authors
6
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2005
Number of shared co-authors
2
Zhongxin Yu
University of Oklahoma Health Sciences Center
Career Start Year
2005
Number of shared co-authors
0
Ke Jin
West China Hospital, Sichuan University
Career Start Year
2005
Number of shared co-authors
0
Yongsoo Kim
College of Medicine, The Pennsylvania State University
Career Start Year
2001
Number of shared co-authors
0
Francisco A Perez
Seattle Children's Hospital
Career Start Year
2000
Number of shared co-authors
0
Chuong Bui
Nepean Hospital
Career Start Year
1999
Number of shared co-authors
0
Patrizia Moser
Medical University of Innsbruck
Career Start Year
1999
Number of shared co-authors
1
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
1
Jun Matsubayashi
Tokyo Medical University
Career Start Year
1996
Number of shared co-authors
0
Eun Young Kim
College of Korean Medicine, Kyung Hee University
Career Start Year
1995
Number of shared co-authors
2
Nam D Tran
Moffitt Cancer Center
Career Start Year
1995
Number of shared co-authors
1
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year
1995
Number of shared co-authors
14
Seung Hoon Lee
Korea University College of Medicine, Korea University Ansan Hospital
Career Start Year
1993
Number of shared co-authors
1
Robert J Weil
Rhode Island Hospital
Career Start Year
1992
Number of shared co-authors
1
Michael Weintraub
Hadassah Hebrew University Hospital
Career Start Year
1992
Number of shared co-authors
3
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year
1992
Number of shared co-authors
0
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year
1992
Number of shared co-authors
1
Andrea Hofmann
Institute of Human Genetics, University of Bonn and Department of Genomics
Career Start Year
1991
Number of shared co-authors
1
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year
1991
Number of shared co-authors
0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year
1988
Number of shared co-authors
0
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1988
Number of shared co-authors
76
Adrienne M Flanagan
University College London, UCL Cancer Institute
Career Start Year
1987
Number of shared co-authors
31
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
1
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year
1983
Number of shared co-authors
4
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
4
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year
1977
Number of shared co-authors
4
John J Mulvihill
University of Oklahoma
Career Start Year
1968
Number of shared co-authors
2
James Sayre
David Geffen School of Medicine at university of california los angeles
Career Start Year
1964
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
45
Annie Huang
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Co-authored papers
17
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers
17
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
15
Guido Reifenberger
Heinrich Heine University
Co-authored papers
15
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
12
Nan Qin
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
11
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
10
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers
10
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
9
Eric Bouffet
The Hospital for Sick Children
Co-authored papers
9
James T Rutka
Hospital for Sick Children
Co-authored papers
8
Gabriel Leprivier
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Co-authored papers
8
Jasmin Bartl
German Cancer Research Center (DKFZ)
Co-authored papers
8
Frauke-Dorothee Meyer
German Cancer Research Center (DKFZ)
Co-authored papers
8
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers
8
David Pauck
German Cancer Research Center (DKFZ)
Co-authored papers
8
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
7
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers
6
Kai St??hler
Universitatsklinikum
Co-authored papers
6
Lena Bl??mel
German Cancer Research Center (DKFZ)
Co-authored papers
6
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
6
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers
5
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers
5
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
5
Olivier Ayrault
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers
5
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
5
Timothy E Van Meter
Virginia Commonwealthy University
Co-authored papers
5
Anja Stefanski
Universitatsklinikum
Co-authored papers
5
Barak Rotblat
Ben-Gurion University of the Negev
Co-authored papers
5
1 - 30